CALLING FOR EARLY BIRDS
Monitor your fatigue with your eyes.
1. Install and setup our app (works with iOS and Android)
2. Follow the dots with your eyes
3. Answer ten survey questions to report your feelings of fatigue
Less than 10 minutes from start-to-finish
Smartphone eye-tracking monitors fatigue
Gaze scatter plot 1
Fatigue score (BFI) = 0.56
Showing gaze points for one participant highlighted, five target locations, gaze points for all participants in the background
Gaze scatter plot 2
Fatigue score (BFI) = 0.2
Clinical Validation
Brief fatigue inventory (BFI)
BFI is a set of 10 multiple choice questions, a self-reported survey on the impact of fatigue in daily life.
Gaze scatter concordance with BFI
mye health eye-tracking index correlates with clinically validated, self-reported fatigue survey, the brief fatigue inventory (BFI).
Source: Tseng, V.WS., Valliappan, N., Ramachandran, V. et al. Digital biomarker of mental fatigue. npj Digit. Med. 4, 47 (2021)
Learn more about us
Fatigue monitoring
mye health index measures gaze scatter, a digital biomarker specific and sensitive to fatigue. Longitudinal monitoring enables early detetection of health issues.
Cognitive health in real-time!
Subtle changes in gaze behavior act as early warning signs.
This feature is in development, coming soon!
Smartphone eye-tracking - the time is now!
Eye-tracking has been limited to clinics with specialized equipment and expertise. Smartphones are now capable of accurate eye-tracking so that specialized tests are much more accessible.
At mye health, we understand the importance of eye-tracking in healthcare.
Seamless monitoring for early detection
We integrate into daily life with the selfie camera whenever you engage your screen – texting, browsing, or watching a video – for continuous monitoring and analysis of eye movements.
Adaptive Learning improves accuracy over time to identify even subtle changes in real-time. This is a game-changer in early detection of disease.
It has been established that pathological changes in the brain occur many years prior to disease onset. Early symptoms include subtle cognitive and memory issues, followed by the phase of Mild Cognitive Impairment (MCI) prior to the established disease. Although the prodromal phase may remain undetected, this is the stage where intervention may be most successful. Eye-tracking can detect the subtle cognitive changes that occur prior to a diagnosis.
Earlier identification of those at risk enables greater impact on prognosis.
Leadership
Dr. Luc Ghislain, CEO
Luc is dedicated to innovation, teamwork, and strategic collaboration. Has an extensive background assembling dynamic teams and launching groundbreaking products. At Labcyte, a cutting-edge biotools startup, he worked across a full spectrum of technologies. He cultivated early adopter technology partnerships with pharma such as AstraZeneca, GSK, and Pfizer. He led a high-throughput analysis instrument from concept to launch -- this was both a real challenge and a highlight. Labcyte was acquired by Beckman Coulter Life Sciences in 2019.
Dr. Lan Guo, CTO
Lan is trained as a Neurophysiologist and conducted basic Neuroscience research for 10 years with a focus on synaptic transmission and neural dynamics. She transitioned into Data Science and Machine learning in industry and has led teams at 3 biotech companies with extensive experience in disease-related model organisms, deep phenotyping and assay development, bioinformatics software development, and machine learning modeling of biological data.
Adivisory Board
Dr. Sammy Datwani
Innovative and strategic results-oriented leader with a demonstrated history developing emergent technologies and commercializing disruptive revolutionary life science and medical device products. 20+ years of executive and leadership experience developing solutions that allow customers to meet their research and commercial objectives. Dynamic team builder and leader for teams spanning multiple functions and locations including R&D, Innovation, Business Development, Corporate Strategy, Product Development, Intellectual Property Development, Program Management, Angel Investing, Fundraising, Startups, Expert Witness and Advocacy.
Gordon Murtaugh
Gordon Murtaugh is a management consultant specializing in helping build early-stage companies. He has operated his own consulting practice for over 20 years, including periods in which he held operating management roles at clients. He has worked with over 50 clients in biotech, pharmaceutical, healthcare, software, finance, manufacturing, renewable energy and professional services. Gordon previously led business development for Philips Healthcare’s consulting business from 2015 to 2018, coming to Philips by way of its acquisition of Blue Jay Consulting, where he had been Vice President. Gordon’s business development team at Philips was responsible for selling management consulting services to hospitals in North America. He also prepared the first business plan for Wellcentive, a population health software company, which was also acquired by Philips Healthcare in 2016. Gordon holds an AB degree in Biochemistry from Brown University and MBA degree from Harvard Business School.
AJ Bubb
Forward-thinking product and engineering leader with over 15 years spanning technology and consulting, guiding cross-functional teams to build innovative and first-to-market products. My career is marked by a series of pioneering roles in cloud computing, AI, and emerging technologies.